GNPX News and Press, Genprex Inc. From 08/14/20

Some technological advancements, such as biomedical engineering, can be used in saving lives because the biomedical engineering field draws knowledge from different disciplines such as computer science, public health, clinical practice and biomedical sciences. The information from these four...

People with type two diabetes are more likely to suffer broken bones than non-diabetic persons. As the number of people with diabetes rises, the skeletal brittleness in persons with type two diabetes is also increasing, and much is not known about the reasons responsible for this reality. The ...

Technology has helped a lot of people to monitor their homes remotely. It has been amazing to use smart doorbells and thermostat applications. Could such techniques also be imported to the health sector? It is possible to cooperate with such technologies, such as Wi-Fi based devices, which may...

A lot of confusion and disbelief is stalling digital contact tracing efforts during the COVID-19 pandemic. A new survey shows that less than 50% of the American respondents support contact tracing apps. This indicates a lack of trust in deploying the technology and could even hinder its effect...

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

Synthetic biology is becoming an important tool in a wide range of applications. In the sector of drug discovery, there are many areas where synthetic biology has played a vital role in faster and accurate drug development at lower expenses. With an increased application of DNA sequencing, syn...

Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, on Thursday announced participation by its chairman and CEO, Rodney Varner, in a second-round live interview on the “Big Biz Show,...

Company to provide update on its lead drug candidate, GPX-001 for non-small cell lung cancer, and its preclinical diabetes gene therapy candidate that may have the potential to cure Type 1 and Type 2 diabetes Genprex, Inc. (“Genprex” or the “Company”) (NAS...

Is the quality of research being compromised during the COVID-19 crisis? It is a question that should be asked by those who are involved in research expeditions. Research studies are crucial in coming up with discoveries; hence a lot of work ethics is always regarded. However, some loopholes m...

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that its Chairman and Chief Executive Officer, Rodney Varne...